Stocks

Johnson & Johnson stock turns up after profit beat, while outlook was mixed

by OverviewFX | Jul 17, 2024 | Stocks

Johnson & Johnson’s stock climbed back into the green in early trading Wednesday, after the drugmaker beat second-quarter profit expectations but trimmed its full-year outlook.

‘She screamed and raged at me’: I have power of attorney for my mother’s $3 million estate — but my sister feels sidelined. How do I get her off my back?

by OverviewFX | Jul 17, 2024 | Stocks

“I want to act ethically and responsibly on behalf of our mother.”

Traders seek clues on likely pace of eurozone rate cuts

by OverviewFX | Jul 17, 2024 | Stocks

The European Central Bank is expected to stand pat on interest rates after its policy meeting on Thursday, emphasizing that it is prepared to be cautious in trimming borrowing costs further without more evidence that inflation will hit its 2% target.

U.S. stocks are headed for their calmest stretch since 2007, by one measure. What that means for your portfolio.

by OverviewFX | Jul 17, 2024 | Stocks

An unusually tranquil stretch for U.S. stocks is poised for a new milestone on Wednesday just as the rally appears to finally be broadening out beyond a handful of megacap names.

Nearly half of U.S. adults struggle to afford healthcare, research shows

by OverviewFX | Jul 17, 2024 | Stocks

Nearly half of U.S. adults are struggling to cover the cost of prescription drugs and doctor visits, new research shows, marking a new low for healthcare affordability.